TJ108
NSCLC
IND-enablingActive
Key Facts
About Phrontline Biopharma
A Chinese biotech developing innovative bispecific dual-payload ADCs to deliver next-generation frontline cancer therapies.
View full company profileTherapeutic Areas
Other NSCLC Drugs
| Drug | Company | Phase |
|---|---|---|
| REQORSA | Genprex | Phase 1/2 |
| HBM7008 | Harbour BioMed | Phase 1 |
| HBM7004 | Harbour BioMed | Discovery |
| LR19125 | AVEO Oncology | Pre-clinical |
| MET FISH CDx | Amoy Diagnostics | Commercial |